Eri Nobusawa

Tokyo, 2080011, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity.

Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity.

Journal: Vaccine
Published: April 06, 2024

Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective.

Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective.

Journal: Vaccine
Published: November 02, 2022

Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields.

Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields.

Journal: PloS one
Published: October 16, 2022

Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility.

Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility.

Journal: Microbiology and immunology
Published: January 26, 2022

Cell-Based Influenza A/H1N1pdm09 Vaccine Viruses Containing Chimeric Hemagglutinin with Improved Membrane Fusion Ability.

Cell-Based Influenza A/H1N1pdm09 Vaccine Viruses Containing Chimeric Hemagglutinin with Improved Membrane Fusion Ability.

Journal: Vaccines
Published: July 09, 2020

Determination of the potency of a cell-based seasonal quadrivalent influenza vaccine using a purified primary liquid standard.

Determination of the potency of a cell-based seasonal quadrivalent influenza vaccine using a purified primary liquid standard.

Journal: Biologicals : journal of the International Association of Biological Standardization
Published: April 23, 2020

Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.

Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.

Journal: Scientific reports
Published: October 09, 2019

Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic.

Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic.

Journal: PloS one
Published: October 03, 2019

A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.

A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.

Journal: Scientific reports
Published: November 17, 2016

Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.

Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.

Journal: Journal of virology
Published: June 30, 2016

Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.

Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.

Journal: PloS one
Published: May 05, 2016

Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.

Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.

Journal: Vaccine
Published: August 03, 2015
Showing 1-12 of 19

Last Updated: 09/26/2026